Tag: influenza diagnostic market cagr

  • Unlocking Opportunities in the Influenza Diagnostic Market: Key Trends, Market Growth, and Forecast Insights

    Unlocking Opportunities in the Influenza Diagnostic Market: Key Trends, Market Growth, and Forecast Insights

    2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

    Which Primary Drivers Are Supporting the Continued Market Growth of theInfluenza Diagnostic Market?

    The demand for rapid diagnostic tests is expected to drive the growth of the influenza diagnostic market. Rapid diagnostic tests provide quick and accurate results, and their use is increasing across healthcare settings. For example, the Australian Institute of Health and Welfare reported an increase in diagnostic imaging services from 28.4 million in 2021-22 to 29.7 million in 2022-23. The growing demand for rapid diagnostic tests is contributing to the growth of the influenza diagnostic market.

    Get Your Free Sample Report Now – Explore Exclusive Market Insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

    #How Will the CAGR of the Influenza Diagnostic Market Influence Its Overall Growth by 2034?

    The influenza diagnostic market has grown strongly in recent years. It is expected to increase from $2.73 billion in 2024 to $2.89 billion in 2025, at a CAGR of 5.9%. This growth is driven by the growth of e-commerce, labor shortages, automation and productivity improvements, supply chain optimization, rising labor costs, and government support for automation and robotics.

    The influenza diagnostic market is expected to see strong growth, reaching $4.01 billion by 2029 at a CAGR of 8.5%. This growth is driven by customization and scalability, environmental and sustainability goals, improving operational efficiency, and modern supply chain dynamics. Major trends include advanced technology integration, robotic picking and packing, autonomous mobile robots, real-time data and analytics, AI-driven decision making, collaborative robots, and advancements in robotic technology.

    You can Directly Purchase the Report Here:

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3237

    Which Cutting-Edge Market Trends Are Expected to Drive theInfluenza Diagnostic Market’s Growth?

    Companies in the influenza diagnostic market are developing innovative products such as the Lucira COVID-19 & Flu Home Test, which allows simultaneous, rapid detection of both COVID-19 and the flu. For instance, in February 2023, Pfizer Inc. received approval for this at-home test kit that can detect influenza A and B and SARS-CoV-2 from self-collected nasal swab samples in about 30 minutes.

    Who Are the Key Market Players Influencing the Growth of the Corn and Influenza Diagnostic Industry?

    Major companies operating in the influenza diagnostic market include F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc., TotalWellness Ltd., Health Advocate Inc., Optum Global Solutions Private Ltd.

    Order Your Report Now For A Swift Delivery:

    https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

    Which Key Market Segments Comprise the Influenza Diagnostic Market and Drive Its Revenue Growth?

    The influenza diagnostic market covered in this report is segmented –

    1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests

    2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests

    3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

    Subsegments:

    1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests, Lateral Flow Assays, Enzyme Immunoassays (EIA)

    2) By Viral Culture: Cell Culture, Egg-based Culture

    3) By Direct Fluorescent Antibody (DFA) Test: Direct Fluorescent Antibody Staining

    4) By Serological Assays: Hemagglutination Inhibition (HI) Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting Assay

    5) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR), Immunofluorescence Assays

    Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

    https://www.thebusinessresearchcompany.com/customise?id=3237&type=smp

    Which Regions Are Emerging as Leaders in the Influenza Diagnostic Market?

    North America was the largest region in the influenza diagnostics market in 2023. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Browse Through More Reports Similar to the Global Influenza Diagnostic Market 2025, By The Business Research Company:

    Immunofluorescence Assay Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report

    Diagnostic Enzyme Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/diagnostic-enzymes-global-market-report

    Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/isothermal-nucleic-acid-amplification-technology-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Analyzing the Future of Influenza Diagnostic Market Dynamics 2025-2034: Growth Rate, Trends, and Major Opportunities

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    What key factors are powering the surge in the influenza diagnostic market right now?

    There has been substantial growth in the influenza diagnostic market size in recent years. An expansion from $2.73 billion in 2024 to $2.89 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.9%, is anticipated. The growth experienced in the historic period is largely due to the boost in e-commerce, labor shortages, automation and productivity, optimization of supply chains, increasing labor costs, and government backing for automation and robotics.

    How fast Is the influenza diagnostic market expected to grow, and what’s its future value?

    Expectations are high for significant expansion in the influenza diagnostic market in the upcoming years. With a compound annual growth rate (CAGR) of 8.5%, the market is anticipated to reach $4.01 billion in 2029. Factors contributing to this predicted growth during the forecast period include the need for customization and scalability, environmental and sustainability targets, efficiency enhancement requirements, and the necessity to conform to the demands of contemporary supply chain dynamics. The forecast period is also likely to witness key trends such as integration of cutting-edge technology, robot-assisted picking and packing, autonomous mobile robots, on-the-spot data and analytics, AI-powered decision making, cooperative robots, and progress in robotic technology.

    Get your influenza diagnostic market report here!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

    What are the leading drivers of growth in the influenza diagnostic market?

    The influenza diagnostic market is projected to be propelled forward by the rise of rapid diagnostic tests. These medical tools or procedures are used to establish or dispel the presence of a condition or disease. With an increasing demand for quick and accurate outcomes in healthcare, Rapid diagnostic tests (RDTs) are on the rise. Rapid influenza diagnostic tests (RIDTs) are capable of identifying influenza viral antigens within 10-15 minutes with a moderate sensitivity of 50-70%. For example, the Australian Institute of Health and Welfare, an Australian government agency that focuses on health and disease information, reported in July 2024 that diagnostic imaging services had increased from 28.4 million in 2021-22 to 29.7 million in 2022-23. Therefore, rapid diagnostic tests are playing a significant part in the expansion of the influenza diagnostic market.

    What are the key segments defining the influenza diagnostic market?

    The influenza diagnostic market covered in this report is segmented –

    1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests

    2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests

    3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

    Subsegments:

    1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests, Lateral Flow Assays, Enzyme Immunoassays (EIA)

    2) By Viral Culture: Cell Culture, Egg-based Culture

    3) By Direct Fluorescent Antibody (DFA) Test: Direct Fluorescent Antibody Staining

    4) By Serological Assays: Hemagglutination Inhibition (HI) Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting Assay

    5) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR), Immunofluorescence Assays

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

    Who are the key players steering the development of the influenza diagnostic market?

    Major companies operating in the influenza diagnostic market include F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc., TotalWellness Ltd., Health Advocate Inc., Optum Global Solutions Private Ltd.

    What emerging trends are influencing the growth of the influenza diagnostic market?

    In the influenza diagnostic market, prominent businesses are introducing state-of-the-art products like the Lucira COVID-19 & Flu Home Test, designed for quick qualitative detection. Its application involves a single-use at-home test kit, providing results from self-obtained nasal swabs in roughly half an hour. An example is Pfizer Inc., a pharmaceutical corporation based in the United States, which secured approval for the Lucira COVID-19 & Flu Home Test in February 2023. This test can identify both influenza A and B, usually referred to as the flu, and SARS-CoV-2, which is the virus causing COVID-19.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3237

    Which regions are most influential in expanding the influenza diagnostic market?

    North America was the largest region in the influenza diagnostics market in 2023. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    Browse Through More Similar Reports By The Business Research Company:

    Immunofluorescence Assay Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report

    Diagnostic Enzyme Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/diagnostic-enzymes-global-market-report

    Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/isothermal-nucleic-acid-amplification-technology-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Influenza Diagnostic Market Trends 2025-2034: Insights into Growth and Strategic Opportunities Ahead

    Influenza Diagnostic Market Trends 2025-2034: Insights into Growth and Strategic Opportunities Ahead

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How Will the Influenza Diagnostic Market’s Growth Rate Evolve Over the Forecast Period to 2034?

    There has been substantial growth in the influenza diagnostic market size in recent years. An expansion from $2.73 billion in 2024 to $2.89 billion in 2025, reflecting a compound annual growth rate (CAGR) of 5.9%, is anticipated. The growth experienced in the historic period is largely due to the boost in e-commerce, labor shortages, automation and productivity, optimization of supply chains, increasing labor costs, and government backing for automation and robotics.

    Expectations are high for significant expansion in the influenza diagnostic market in the upcoming years. With a compound annual growth rate (CAGR) of 8.5%, the market is anticipated to reach $4.01 billion in 2029. Factors contributing to this predicted growth during the forecast period include the need for customization and scalability, environmental and sustainability targets, efficiency enhancement requirements, and the necessity to conform to the demands of contemporary supply chain dynamics. The forecast period is also likely to witness key trends such as integration of cutting-edge technology, robot-assisted picking and packing, autonomous mobile robots, on-the-spot data and analytics, AI-powered decision making, cooperative robots, and progress in robotic technology.

    How Are the key drivers expanding the growth of the Influenza Diagnostic Market?

    The influenza diagnostic market is projected to be propelled forward by the rise of rapid diagnostic tests. These medical tools or procedures are used to establish or dispel the presence of a condition or disease. With an increasing demand for quick and accurate outcomes in healthcare, Rapid diagnostic tests (RDTs) are on the rise. Rapid influenza diagnostic tests (RIDTs) are capable of identifying influenza viral antigens within 10-15 minutes with a moderate sensitivity of 50-70%. For example, the Australian Institute of Health and Welfare, an Australian government agency that focuses on health and disease information, reported in July 2024 that diagnostic imaging services had increased from 28.4 million in 2021-22 to 29.7 million in 2022-23. Therefore, rapid diagnostic tests are playing a significant part in the expansion of the influenza diagnostic market.

    Get Your Free Sample of the Global Influenza Diagnostic Market Report Now!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=3237&type=smp

    Who Are the Influential Players Reshaping the Influenza Diagnostic Market Landscape?

    Major companies operating in the influenza diagnostic market include F. Hoffmann-La Roche Ltd., Quidel Corporation, Thermo Fisher Scientific Inc., Abbott Laboratories, Hologic Inc., Becton Dickinson and Company, DiaSorin SpA, Luminex Corporation, Meridian Bioscience Inc., GenMark Diagnostics Inc., SA Scientific Ltd., Sekisui Diagnostics LLC, bioMérieux Inc., Danaher Corporation, Siemens Healthineers AG, Coris Bioconcept Sprl, Mast Group, Elitech Technology lnc., Analytik Jena AG, altona Diagnostics GmbH, Tecan Trading AG, Genome Diagnostics Pvt Ltd., Germaine Laboratories Inc., Response Biomedical Corporation, TAUNS Laboratories Inc., TRUPCR Europe Ltd., Quest Diagnostics Inc., Labcorp Employer Services Inc., TotalWellness Ltd., Health Advocate Inc., Optum Global Solutions Private Ltd.

    What Current Trends in the Influenza Diagnostic Market Should Industry Players Pay Attention To?

    In the influenza diagnostic market, prominent businesses are introducing state-of-the-art products like the Lucira COVID-19 & Flu Home Test, designed for quick qualitative detection. Its application involves a single-use at-home test kit, providing results from self-obtained nasal swabs in roughly half an hour. An example is Pfizer Inc., a pharmaceutical corporation based in the United States, which secured approval for the Lucira COVID-19 & Flu Home Test in February 2023. This test can identify both influenza A and B, usually referred to as the flu, and SARS-CoV-2, which is the virus causing COVID-19.

    Get Instant Access to the Global Influenza Diagnostic Market Report with Swift Delivery!

    https://www.thebusinessresearchcompany.com/report/influenza-diagnostic-global-market-report

    How Are the Key Segments of the Influenza Diagnostic Market Impacting Its Expansion and Revenue Streams?

    The influenza diagnostic market covered in this report is segmented –

    1) By Traditional diagnostic tests: Rapid influenza diagnostic tests (RIDT), Viral Culture, DFA, Serological assays, Other Traditional diagnostic tests

    2) By Molecular diagnostic tests: Reverse Transcription Polymerase Chain Reaction (RT-PCR), Isothermal Nucleic Acid Amplification Tests (INAAT), Loop Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Transcription Mediated Isothermal Based Amplification Assays, Other Isothermal Nucleic Acid Amplification Tests, Other Molecular Diagnostic Tests

    3) By End User: Hospitals And Clinical Laboratories, Diagnostic Reference Laboratories, Academic/Research Institutes, Other End Users

    Subsegments:

    1) By Rapid Influenza Diagnostic Tests (RIDT): Immunoassay-based Tests, Lateral Flow Assays, Enzyme Immunoassays (EIA)

    2) By Viral Culture: Cell Culture, Egg-based Culture

    3) By Direct Fluorescent Antibody (DFA) Test: Direct Fluorescent Antibody Staining

    4) By Serological Assays: Hemagglutination Inhibition (HI) Assay, Enzyme-Linked Immunosorbent Assay (ELISA), Western Blotting Assay

    5) By Other Traditional Diagnostic Tests: Polymerase Chain Reaction (PCR), Immunofluorescence Assays

    Which Geographic Locations Are Critical to the Growth of the Influenza Diagnostic Market?

    North America was the largest region in the influenza diagnostics market in 2023. Western Europe was the second largest region in the influenza diagnostics market. The regions covered in the influenza diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    What Are the Key Characteristics That Define the Influenza Diagnostic Market?

    Influenza diagnostic is the test used to diagnose influenza including viral culture, serology, rapid antigen testing, reverse transcription-polymerase chain reaction (RT-PCR), immunofluorescence assays, and rapid molecular assays. Influenza, commonly known as flu, is a contagious illness caused by the influenza virus. Three varieties of this virus affect people: type A, type B, and type C. Common symptoms include fever, sore throat, cough, body ache, fatigue, and headache. The market consists of revenues generated by establishments conducting diagnostics tests for influenza virus detection.

    Browse Through More Similar Reports By The Business Research Company:

    Immunofluorescence Assay Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/immunofluorescence-assay-global-market-report

    Diagnostic Enzyme Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/diagnostic-enzymes-global-market-report

    Isothermal Nucleic Acid Amplification Technology (INAAT) Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/isothermal-nucleic-acid-amplification-technology-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on: